These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 24341820)

  • 61. Use of procalcitonin for the prediction and treatment of acute bacterial infection in children.
    Pierce R; Bigham MT; Giuliano JS
    Curr Opin Pediatr; 2014 Jun; 26(3):292-8. PubMed ID: 24739491
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Procalcitonin as a biomarker of infectious diseases.
    Lee H
    Korean J Intern Med; 2013 May; 28(3):285-91. PubMed ID: 23682219
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Characteristics of procalcitonin in hospitalized COVID-19 patients and clinical outcomes of antibiotic use stratified by procalcitonin levels.
    So W; Simon MS; Choi JJ; Wang TZ; Williams SC; Chua J; Kubin CJ
    Intern Emerg Med; 2022 Aug; 17(5):1405-1412. PubMed ID: 35277828
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Procalcitonin guidance of antibiotic therapy in community-acquired pneumonia: a randomized trial.
    Christ-Crain M; Stolz D; Bingisser R; Müller C; Miedinger D; Huber PR; Zimmerli W; Harbarth S; Tamm M; Müller B
    Am J Respir Crit Care Med; 2006 Jul; 174(1):84-93. PubMed ID: 16603606
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Differential diagnosis of bacterial infection and inflammatory response in kidney diseases using procalcitonin.
    Sitter T; Schmidt M; Schneider S; Schiffl H
    J Nephrol; 2002; 15(3):297-301. PubMed ID: 12113602
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Procalcitonin is a specific marker for detecting bacterial infection in patients with rheumatoid arthritis.
    Sato H; Tanabe N; Murasawa A; Otaki Y; Sakai T; Sugaya T; Ito S; Otani H; Abe A; Ishikawa H; Nakazono K; Kuroda T; Nakano M; Narita I
    J Rheumatol; 2012 Aug; 39(8):1517-23. PubMed ID: 22753652
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Meta-analysis and systematic review of procalcitonin-guided therapy in respiratory tract infections.
    Li H; Luo YF; Blackwell TS; Xie CM
    Antimicrob Agents Chemother; 2011 Dec; 55(12):5900-6. PubMed ID: 21947386
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The Procalcitonin-guided Antibiotics in Respiratory Infections (PARI) project in general practice - a study protocol.
    Filipsen N; Bro H; Bjerrum L; Jensen JS; Aabenhus R
    BMC Prim Care; 2022 Mar; 23(1):43. PubMed ID: 35279069
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Procalcitonin levels in acute exacerbation of COPD admitted in ICU: a prospective cohort study.
    Daubin C; Parienti JJ; Vabret A; Ramakers M; Fradin S; Terzi N; Freymuth F; Charbonneau P; du Cheyron D
    BMC Infect Dis; 2008 Oct; 8():145. PubMed ID: 18947382
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Rationale and design of the IMPACT EU-trial: improve management of heart failure with procalcitonin biomarkers in cardiology (BIC)-18.
    Möckel M; Slagman A; Vollert JO; Ebmeyer S; Wiemer JC; Searle J; Giannitsis E; Kellum JA; Maisel A
    Biomarkers; 2018 Feb; 23(1):97-103. PubMed ID: 29264937
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Serum procalcitonin measurement as diagnostic and prognostic marker in febrile adult patients presenting to the emergency department.
    Hausfater P; Juillien G; Madonna-Py B; Haroche J; Bernard M; Riou B
    Crit Care; 2007; 11(3):R60. PubMed ID: 17521430
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Potential of serum procalcitonin in predicting bacterial exacerbation and guiding antibiotic administration in severe COPD exacerbations: a systematic review and meta-analysis.
    Ni W; Bao J; Yang D; Xi W; Wang K; Xu Y; Zhang R; Gao Z
    Infect Dis (Lond); 2019 Sep; 51(9):639-650. PubMed ID: 31355690
    [No Abstract]   [Full Text] [Related]  

  • 73. Procalcitonin for diagnosis of infection and guide to antibiotic decisions: past, present and future.
    Schuetz P; Albrich W; Mueller B
    BMC Med; 2011 Sep; 9():107. PubMed ID: 21936959
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Is serum procalcitonin a reliable diagnostic marker in children with acute respiratory tract infections? A retrospective analysis.
    Schützle H; Forster J; Superti-Furga A; Berner R
    Eur J Pediatr; 2009 Sep; 168(9):1117-24. PubMed ID: 19107517
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Procalcitonin in the early phase after renal transplantation--will it add to diagnostic accuracy?
    Eberhard OK; Langefeld I; Kuse ER; Brunkhorst FM; Kliem V; Schlitt HJ; Pichlmayr R; Koch KM; Brunkhorst R
    Clin Transplant; 1998 Jun; 12(3):206-11. PubMed ID: 9642511
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Inflammatory cytokines, C reactive protein, and procalcitonin as early predictors of necrosis infection in acute necrotizing pancreatitis.
    Riché FC; Cholley BP; Laisné MJ; Vicaut E; Panis YH; Lajeunie EJ; Boudiaf M; Valleur PD
    Surgery; 2003 Mar; 133(3):257-62. PubMed ID: 12660636
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Procalcitonin variations after Emergency Department admission are highly predictive of hospital mortality in patients with acute infectious diseases.
    Magrini L; Travaglino F; Marino R; Ferri E; De Berardinis B; Cardelli P; Salerno G; Di Somma S
    Eur Rev Med Pharmacol Sci; 2013 Feb; 17 Suppl 1():133-42. PubMed ID: 23436675
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Cutoff value of serum procalcitonin as a diagnostic biomarker of infection in end-stage renal disease patients.
    Lee WS; Kang DW; Back JH; Kim HL; Chung JH; Shin BC
    Korean J Intern Med; 2015 Mar; 30(2):198-204. PubMed ID: 25750561
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Procalcitonin: a reliable marker for the diagnosis and monitoring of the course of bacterial infection].
    Holub M; Rozsypal H; Chalupa P
    Klin Mikrobiol Infekc Lek; 2008 Dec; 14(6):201-8. PubMed ID: 19214953
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Procalcitonin in heart failure: hic et nunc.
    Cvetinovic N; Isakovic AM; Lainscak M; Dungen HD; Nikolic NM; Loncar G
    Biomark Med; 2017 Oct; 11(10):893-903. PubMed ID: 28976777
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.